The global incidence of basal cell carcinoma is increasing due to prolonged exposure to ultraviolet (UV) radiation, genetic predispositions, and an aging population that is more susceptible to skin ...
TipRanks on MSN
Philogen’s new phase 2 study: A potential game-changer in basal cell carcinoma treatment
Philogen SpA ($DE:78Q) announced an update on their ongoing clinical study. Philogen S.p.A. is conducting a Phase 2 clinical study titled ‘A Phase ...
Medicus Pharma Ltd. announced promising interim results from its SKNJCT-003 Phase 2 clinical study aimed at the non-invasive treatment of basal cell carcinoma (BCC) using the investigational product D ...
Medicus Pharma has announced the completion of patient enrollment for its phase 2 SKNJCT-003 trial, evaluating the safety and ...
Detailed price information for Biofrontera Inc (BFRI-Q) from The Globe and Mail including charting and trades.
FourStatesHomepage.com on MSN
Gordon Ramsay reveals skin cancer diagnosis, tells fans to wear sunscreen
Basal Cell Carcinoma is usually found in parts of the skin that’s typically exposed to the sun, such as your head and neck.
DURHAM, N.C. – A new study reveals that small cell lung cancer (SCLC) likely begins in basal stem-like cells rather than in neuroendocrine cells, marking a major shift in the understanding of this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results